Literature DB >> 20053355

Rapid structural characterization of human antibody-antigen complexes through experimentally validated computational docking.

Luca Simonelli1, Martina Beltramello, Zinaida Yudina, Annalisa Macagno, Luigi Calzolai, Luca Varani.   

Abstract

If we understand the structural rules governing antibody (Ab)-antigen (Ag) interactions in a given virus, then we have the molecular basis to attempt to design and synthesize new epitopes to be used as vaccines or optimize the antibodies themselves for passive immunization. Comparing the binding of several different antibodies to related Ags should also further our understanding of general principles of recognition. To obtain and compare the three-dimensional structure of a large number of different complexes, however, we need a faster method than traditional experimental techniques. While biocomputational docking is fast, its results might not be accurate. Combining experimental validation with computational prediction may be a solution. As a proof of concept, here we isolated a monoclonal Ab from the blood of a human donor recovered from dengue virus infection, characterized its immunological properties, and identified its epitope on domain III of dengue virus E protein through simple and rapid NMR chemical shift mapping experiments. We then obtained the three-dimensional structure of the Ab/Ag complex by computational docking, using the NMR data to drive and validate the results. In an attempt to represent the multiple conformations available to flexible Ab loops, we docked several different starting models and present the result as an ensemble of models equally agreeing with the experimental data. The Ab was shown to bind a region accessible only in part on the viral surface, explaining why it cannot effectively neutralize the virus. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20053355     DOI: 10.1016/j.jmb.2009.12.053

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  13 in total

1.  The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity.

Authors:  Martina Beltramello; Katherine L Williams; Cameron P Simmons; Annalisa Macagno; Luca Simonelli; Nguyen Than Ha Quyen; Soila Sukupolvi-Petty; Erika Navarro-Sanchez; Paul R Young; Aravinda M de Silva; Félix A Rey; Luca Varani; Stephen S Whitehead; Michael S Diamond; Eva Harris; Antonio Lanzavecchia; Federica Sallusto
Journal:  Cell Host Microbe       Date:  2010-09-16       Impact factor: 21.023

Review 2.  Protein engineering strategies for the development of viral vaccines and immunotherapeutics.

Authors:  Jayne F Koellhoffer; Chelsea D Higgins; Jonathan R Lai
Journal:  FEBS Lett       Date:  2013-10-21       Impact factor: 4.124

3.  A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential.

Authors:  Jiaqi Wang; Marco Bardelli; Diego A Espinosa; Mattia Pedotti; Thiam-Seng Ng; Siro Bianchi; Luca Simonelli; Elisa X Y Lim; Mathilde Foglierini; Fabrizia Zatta; Stefano Jaconi; Martina Beltramello; Elisabetta Cameroni; Guntur Fibriansah; Jian Shi; Taylor Barca; Isabel Pagani; Alicia Rubio; Vania Broccoli; Elisa Vicenzi; Victoria Graham; Steven Pullan; Stuart Dowall; Roger Hewson; Simon Jurt; Oliver Zerbe; Karin Stettler; Antonio Lanzavecchia; Federica Sallusto; Andrea Cavalli; Eva Harris; Shee-Mei Lok; Luca Varani; Davide Corti
Journal:  Cell       Date:  2017-09-21       Impact factor: 41.582

4.  Modeling and docking of antibody structures with Rosetta.

Authors:  Brian D Weitzner; Jeliazko R Jeliazkov; Sergey Lyskov; Nicholas Marze; Daisuke Kuroda; Rahel Frick; Jared Adolf-Bryfogle; Naireeta Biswas; Roland L Dunbrack; Jeffrey J Gray
Journal:  Nat Protoc       Date:  2017-01-26       Impact factor: 13.491

5.  Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus.

Authors:  Davide Corti; Jincun Zhao; Mattia Pedotti; Luca Simonelli; Sudhakar Agnihothram; Craig Fett; Blanca Fernandez-Rodriguez; Mathilde Foglierini; Gloria Agatic; Fabrizia Vanzetta; Robin Gopal; Christopher J Langrish; Nicholas A Barrett; Federica Sallusto; Ralph S Baric; Luca Varani; Maria Zambon; Stanley Perlman; Antonio Lanzavecchia
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-27       Impact factor: 11.205

6.  Redesign of a cross-reactive antibody to dengue virus with broad-spectrum activity and increased in vivo potency.

Authors:  Kannan Tharakaraman; Luke N Robinson; Andrew Hatas; Yi-Ling Chen; Liu Siyue; S Raguram; V Sasisekharan; Gerald N Wogan; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-08       Impact factor: 11.205

Review 7.  Computer-aided antibody design.

Authors:  Daisuke Kuroda; Hiroki Shirai; Matthew P Jacobson; Haruki Nakamura
Journal:  Protein Eng Des Sel       Date:  2012-06-02       Impact factor: 1.650

8.  Computational docking of antibody-antigen complexes, opportunities and pitfalls illustrated by influenza hemagglutinin.

Authors:  Mattia Pedotti; Luca Simonelli; Elsa Livoti; Luca Varani
Journal:  Int J Mol Sci       Date:  2011-01-05       Impact factor: 5.923

9.  Rational engineering of a human anti-dengue antibody through experimentally validated computational docking.

Authors:  Luca Simonelli; Mattia Pedotti; Martina Beltramello; Elsa Livoti; Luigi Calzolai; Federica Sallusto; Antonio Lanzavecchia; Luca Varani
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

10.  Epitope mapping and in silico characterization of interactions between Der p 7 allergen and MoAb WH9.

Authors:  Hsiao-Yun Tai; Jia-Kai Zhou; Hong Chou; Ming F Tam; Yu-Sen Chen; Sheh-Yi Sheu; Horng-Der Shen
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.